Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016 - 6 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Overview
  3. Therapeutics Development
  4. Pipeline Products for Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Overview
  5. Pipeline Products for Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Comparative Analysis
  6. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Therapeutics under Development by Companies
  7. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Therapeutics under Investigation by Universities/Institutes
  8. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Products under Development by Companies
  13. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Products under Investigation by Universities/Institutes
  14. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Companies Involved in Therapeutics Development
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Chong Kun Dang Pharmaceutical Corp.
  • Kowa Company, Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.

For more information visit http://www.researchandmarkets.com/research/fp2rzr/cholesteryl_ester

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716